avian influenza

change direction new plan alter arrows move reprioritize

Biotech

CureVac gains $430M GSK vaccine contract, loses 30% of staff

CureVac shared news of the deal alongside a restructuring that will put 30% of its employees out of work and extend its cash runway into 2028.

Nick Paul Taylor Jul 3, 2024 5:00am

An artists depiction of an orange chicken pulling what is presumably a large influenza virus particle

NIAID is 'on the ball' with bird flu research, but gaps remain

Jun 10, 2024 5:50am